Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease

Kristen K. Lee(Albert Einstein College of Medicine), Jean‐Frédéric Colombel(Mount Sinai Hospital), E Maser(Icahn School of Medicine at Mount Sinai), Bindia Jharap(Meander Medisch Centrum)

Inflammatory Bowel Diseases

September 2, 2015

10.1097/mib.0000000000000577

Cited by 26

Related Papers

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

|New England Journal of Medicine|2005|3.9k

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

|New England Journal of Medicine|2013|2.9k

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

|New England Journal of Medicine|2013|2.7k

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

|Gastroenterology|2021|2.6k

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

|Nature Genetics|2011|1.4k